Nishita Thota

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

Jaya Singh, Nishita Thota, Suhasini Singh et al. · Breast Cancer Research and Treatment · 2018 · 93 citations

Indian Patients, Breast Oncology, Medicine +10

P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib

Mark C. de Gooijer, Ping Zhang, Nishita Thota et al. · Investigational New Drugs · 2015 · 83 citations · Full text

Cdk4/6 Inhibitor Palbociclib, Medicine, Receptor Tyrosine Kinase +6

PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models

Fan Lin, Mark C. de Gooijer, Diana Hanekamp et al. · Clinical Cancer Research · 2016 · 80 citations · Full text

Buparlisib is a brain penetrable pan-PI3K inhibitor

Mark C. de Gooijer, Ping Zhang, Levi C.M. Buil et al. · Scientific Reports · 2018 · 80 citations · Full text

Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India

Ashraf U. Mannan, Jaya Singh, Ravikiran Lakshmikeshava et al. · Journal of Human Genetics · 2016 · 74 citations

Molecular Diagnosis, Genetic Testing, Somatic Variant +11